The Relationship With Mad Honey Containing Grayanotoxin and Ovary Tissue
NCT ID: NCT05643599
Last Updated: 2025-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
2022-12-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Group 1 was given mad honey (n:6) (80 mg/kg); Group 2 was given normal honey (n:6) (80 mg/kg), and Group 3 was the control group (n:6). The groups were given normal and mad honey by oral gavage for 30 days in this study. Rats were anesthetized intramuscularly with 50 mg/kg ketamine and 5 mg/kg xylazine on the 30th day of the study. At the conclusion of the study, female rats in the proestrus phase of the estrous cycle (as indicated by vaginal smear) were sacrificed and their ovarian tissues were placed in neutral formalin solution.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ovarian Reserve in Diabetes Mellitus
NCT03859856
Efficacy and Safety of HPC-03 for Postmenopausal Symptom
NCT03061799
Short Term Ketogenic Diet in Polycictic Ovary Syndrome
NCT06469255
The Results of the Mediterranean Diet for PCOS
NCT06442189
Ovarian Hyperstimulation Syndrome and Cabergoline
NCT01569256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1:
Mad honey
Mad Honey
mad honey (80 mg/kg); (n:6)
Group 2:
Normal honey
Normal Honey
normal honey (80 mg/kg),(n:6)
Group 3:
without intervention
Control
Control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mad Honey
mad honey (80 mg/kg); (n:6)
Normal Honey
normal honey (80 mg/kg),(n:6)
Control
Control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* not eating rats
8 Weeks
10 Weeks
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Celal Bayar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hayrunnisa Yesil Sarsmaz
Asistant Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gulsen Gurgen
Role: STUDY_CHAIR
Manisa Celal Bayar University
Suha Turkmen
Role: STUDY_CHAIR
Karadeniz Teknik University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hayrunnisa
Yunusemre, Mani̇sa, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCBU_Madhoney
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.